Search research articles
Contact Us
Filters
Showing results (301-310 of 415) with videos related to
Page
of 42
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
March 7, 2020
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617
Justin Ferdinandus, John Violet, Shahneen Sandhu, et al.
Therapeutic Advances in Medical Oncology
|
June 16, 2023
Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature review
Duncan E K Sutherland, Raghava Kashyap, Price Jackson, et al.
European Urology Focus
|
May 3, 2022
Gender Disparities Among Editorial Boards of International Urology Journals
Madeleine L Burg, Tamir Sholklapper, Priya Kohli, et al.
Pathology
|
January 15, 2011
Prostate tumour volume is an independent predictor of early biochemical recurrence in a high risk radical prostatectomy subgroup
Matthew K H Hong, Benjamin Namdarian, Niall M Corcoran, et al.
BJU International
|
March 15, 2016
Validation of the novel International Society of Urological Pathology 2014 five-tier Gleason grade grouping: biochemical recurrence rates for 3+5 disease may be overestimated
Roderick C N van den Bergh, Theo H van der Kwast, Jeroen de Jong, et al.
Trials
|
January 12, 2021
Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners
Penelope Schofield, Karla Gough, Amelia Hyatt, et al.
European Urology
|
November 5, 2019
Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis
Niranjan J Sathianathen, Samantha Koschel, Isaac A Thangasamy, et al.
BJU International
|
June 12, 2023
Treatment de-intensification for low-risk biochemical recurrence after radical prostatectomy: rational or risky?
Matthew J Roberts, George Hruby, Andrew Kneebone, et al.
European Urology
|
January 7, 2015
Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy
Giacomo Novara, James W F Catto, Timothy Wilson, et al.
BJU International
|
February 12, 2017
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial
Shankar Siva, Daniel Pham, Tomas Kron, et al.
Page
of 42
Search research articles
Search
Showing results (301-310 of 415) with videos related to
Sort By:
Page
of 42
European Journal of Nuclear Medicine and Molecular Imaging
|
March 7, 2020
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617
Justin Ferdinandus, John Violet, Shahneen Sandhu, et al.
Therapeutic Advances in Medical Oncology
|
June 16, 2023
Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature review
Duncan E K Sutherland, Raghava Kashyap, Price Jackson, et al.
European Urology Focus
|
May 3, 2022
Gender Disparities Among Editorial Boards of International Urology Journals
Madeleine L Burg, Tamir Sholklapper, Priya Kohli, et al.
Pathology
|
January 15, 2011
Prostate tumour volume is an independent predictor of early biochemical recurrence in a high risk radical prostatectomy subgroup
Matthew K H Hong, Benjamin Namdarian, Niall M Corcoran, et al.
BJU International
|
March 15, 2016
Validation of the novel International Society of Urological Pathology 2014 five-tier Gleason grade grouping: biochemical recurrence rates for 3+5 disease may be overestimated
Roderick C N van den Bergh, Theo H van der Kwast, Jeroen de Jong, et al.
Trials
|
January 12, 2021
Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners
Penelope Schofield, Karla Gough, Amelia Hyatt, et al.
European Urology
|
November 5, 2019
Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis
Niranjan J Sathianathen, Samantha Koschel, Isaac A Thangasamy, et al.
BJU International
|
June 12, 2023
Treatment de-intensification for low-risk biochemical recurrence after radical prostatectomy: rational or risky?
Matthew J Roberts, George Hruby, Andrew Kneebone, et al.
European Urology
|
January 7, 2015
Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy
Giacomo Novara, James W F Catto, Timothy Wilson, et al.
BJU International
|
February 12, 2017
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial
Shankar Siva, Daniel Pham, Tomas Kron, et al.
Page
of 42